TTP607

· MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TTP607, covering 2012-07-31 to 2012-07-31. Get the full timeline:

Most recent: Clinical Trial Update: TTP607 in Refractory Solid Malignancies [Phase 1]